Intelligent Bio Solutions (INBS) Non-Current Assets (2020 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Non-Current Assets of $4.1 million in Q2 2025, down 8.18% quarter-over-quarter from $4.5 million in Q1 2025, and down 21.61% on a YoY basis from $5.2 million in Q2 2024.
Intelligent Bio Solutions (INBS) Non-Current Assets (2020 - 2025) Analysis & Trends
Intelligent Bio Solutions' Non-Current Assets history runs 6 years deep, the most recent figure standing at $4.1 million for Q2 2025.
- In Q2 2025, Non-Current Assets fell 21.61% year-over-year to $4.1 million; the TTM figure through Jun 2025 stood at $4.1 million (down 21.61% YoY), while the FY2025 annual figure was $4.1 million, down 21.61% from the prior year.
- Non-Current Assets was $4.1 million for Q2 2025 at Intelligent Bio Solutions, down from $4.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $11.7 million in Q4 2022 to a low of $866667.0 in Q1 2021.
- Historically, Non-Current Assets has averaged $4.4 million across 5 years, with a median of $4.5 million in 2024.
- The sharpest annual moves came in 2021 and 2022: Non-Current Assets soared 2591.63% in 2021, then sank 59.36% in 2022.
- A 5-year view of Non-Current Assets shows it stood at $1.2 million in 2021, then surged by 913.9% to $11.7 million in 2022, then tumbled by 49.59% to $5.9 million in 2023, then retreated by 21.42% to $4.6 million in 2024, then decreased by 11.06% to $4.1 million in 2025.
- The last three Non-Current Assets figures came in at $4.1 million (Q2 2025), $4.5 million (Q1 2025), and $4.6 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | 4.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.11 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | 5.25 Mn |
| Jun 30, 2024 | 5.24 Mn |
| Mar 31, 2024 | 5.52 Mn |
| Dec 31, 2023 | 5.88 Mn |
| Sep 30, 2023 | 6.01 Mn |
| Jun 30, 2023 | 6.49 Mn |
| Mar 31, 2023 | 6.25 Mn |
| Dec 31, 2022 | 11.67 Mn |
| Sep 30, 2022 | 1.95 Mn |
| Jun 30, 2022 | 1.48 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 3.25 Mn |
| Jun 30, 2021 | 3.65 Mn |
| Mar 31, 2021 | 866,667.00 |
| Jun 30, 2020 | 135,692.00 |